CELZ

Official X Account for CREATIVE MEDICAL TECHNOLOGY HOLDINGS, Inc
Cell Therapy & AI Therapeutics
$CELZ

[CELZ @CELZonNASDAQ]

Great progress with the ADAPT back pain trial and expansion to opioid requiring patients. Almost complete enrollment. Go Team. https://t.co/v0V6Vdcmaq

[CELZ @CELZonNASDAQ]

Project PHOENIX continues to support veterans who have had burn pit exposure for FREE.
Learn More @ https://t.co/tN7LQumOO2
Stay up to date @ CELZ on NASDAQ

[CELZ @CELZonNASDAQ]

Congratulations to our partners @GreenstoneBio for collaborating with @intel to scale AI-enabled drug discovery. The future for #AIinbiotech is looking bright!
#CELZ #BioDefense #DrugDiscovery

[CELZ @CELZonNASDAQ]

The PHOENIX program helping our veterans with burn pit exposure using revolutionary #AI solutions is going full throttle with great success. https://t.co/gLSyu7WEF9 #burnpit . $CELZ
https://t.co/kBdRIRZdPM

[CELZ @CELZonNASDAQ]

Positive interim data for #back #pain with #olastrocel No current need for fund raising to continue all programs $celz

[CELZ @CELZonNASDAQ]

$CELZ Creative Medical Technology Holdings Reaches Major Clinical Inflection Point with Positive Interim Data from ADAPT Trial and CELZ-201 (Olastrocel) in the Treatment of Chronic Lower Back Pain
https://t.co/PKuCygGmgQ

[CELZ @CELZonNASDAQ]

Great news to support our veterans who were exposed to burn 🔥 pits without further fund raising. More clinical data soon $celz #bio #Defence

[CELZ @CELZonNASDAQ]

Happy New Year. We look forward to supporting our great patients and Clincial programs with data coming out soon. $celz #pain #cell #usa #opiod

[CELZ @CELZonNASDAQ]

$CELZ Creative Medical Technology Holdings, Inc. Ignites Next-Gen Regenerative BioDefense Initiative for U.S. Veterans Exposed to Burn Pits
https://t.co/LqM4GEnXYf

[CELZ @CELZonNASDAQ]

🇺🇸 Transforming Thank You into Action. Today, we’re proud to launch our first-of-its-kind BioDefense initiative for U.S. veterans exposed to burn pits. With our proprietary iPSC & AI-powered regenerative platform, we’re tackling toxic-exposure damage head-on. https://t.co/mqGZ5UHmVJ

This isn’t just biotech—it’s national health security. We stand with those who stood for us. #Veterans #RegenerativeMedicine #BioDefense #CELZ $NVIDIA #greenstonebio #AI #BioDefense #RegenerativeMedicine #MilitaryHealth #BiotechStocks
@DeptVetAffairs @USArmy @USNavy @USMC @USAirForce @DeptofWar @SecWar

[CELZ @CELZonNASDAQ]

Rapid enrollment and continuing on the recent news for FDA Fast Track Approval. https://t.co/drDHoAL8Pq #backpainrelief

[CELZ @CELZonNASDAQ]

$CELZ Exciting news. Another patent for the Immcelz program granted. Prevention and/or Treatment of Type 1 Diabetes by Augmentation of Myeloid Suppressor Cell Activity. https://t.co/ZdPSxgwVB4
#diabetes #uspto #BreakingNews‌ #LoveIsland

[CELZ @CELZonNASDAQ]

Breaking News🚨

CELZ has been granted a very broad patent on the TREATMENT OF HEART FAILURE AND/OR POST INFARCT PATHOLOGICAL REMODELING BY EX VIVO REPROGRAMMED IMMUNE CELLS on people who are at risk or have heart failure.

This is a great patent for the ImmCelz program.

https://t.co/d7urMIbHM1

[PatentGrants @PatentGrants]

$CELZ Creative Medical Technology has received a Notice of Allowance for a US patent titled "TREATMENT OF HEART FAILURE AND/OR POST INFARCT PATHOLOGICAL REMODELING BY EX VIVO REPROGRAMMED IMMUNE CELLS". https://t.co/PRCHzBXSX2

[CELZ @CELZonNASDAQ]

https://t.co/5ucPT8blaL

[John Zidar aka/ Stock Wizard @JohnZidar]

$CELZ - Creative Medical Technology Holdings
🔹Secures FDA Clearance for Expanded Dose Escalation in the Clinical Trial of CELZ-201-DDT for Chronic Lower Back Pain
🔹Positive interim data showing statistically significant pain reduction and mobility improvement
🔹Strong safety profile with no serious adverse events reported
🔹FDA clearance for expanded dose escalation obtained
🔹Trial progressing on schedule toward potential Phase 3 study
🔹Very Low Float/ OS near 2M shares

👆 5.6% PreM/ $3.24

[Hottest Stocks Now @HottestStockNow]

Creative Medical Technology: FDA OKs Expanded Dose Escalation in the Clinical Trial of CELZ-201-DDT for Chronic Lower Back Pain $CELZ, #CreativeMedicalTechnology, #CreativeMedical, #CMTH_Inc, #CMTHInc https://t.co/aK54C3Axif

[The Stock Trader Hub Zee @TSTHZeee]

Creative Medical Says FDA Cleared Expanded Dose Escalation For Phase 1/2 Trial Of StemSpine Using AlloStem For Chronic Lower Back Pain $CELZ